Reporting 7 Pompe Patients in Iran

Summary: Study of Pompe disease in Iran shows diagnosis delays from 6 months to 28 years, impacting patient outcomes. #PompeDisease #RareDisease

Ebrahimi M¹ ; Rouzbahani R² ; Pourfarzam M³
Source: Journal of Isfahan Medical School Published:2017

Abstract

Background: Pompe is a progressive and rare disease with major form (infantile form) resulted from lack of lysosomal alpha-glucosidase enzyme. This disease inherits in an autosomal recessive form and contains spectrum of different symptoms based on the age of onset. The variety of symptoms has seen in this disease like muscle weakness, cardio pulmonary problems, disability in daily routine works, and so on. Case Report: In this case study, we studied the characteristics of 7 established patients in Iran recognized from 8 years ago. The age range of these patients was from 6 months to 28 years. Conclusion: Different diagnosis time in patients, which is important, in this study was between 6 months to 28 years, which could cause many problems in patients whom their diagnosis was delayed. © 2017, Isfahan University of Medical Sciences(IUMS). All rights reserved.